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A Case of Anti-Myelin Oligodendrocyte Glycoprotein 
Antibody-Positive Late-Onset Acute 
Disseminated Encephalomyelitis 
Dear Editor, 
Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease (MOGAD) 
has recently been classified as a distinct inflammatory demyelinating disease of the central 
nervous system.1 The clinical manifestations of adult MOGAD resemble those of neuromye-
litis optica spectrum disorder (NMOSD), which usually involve the optic nerve and spinal 
cord. When MOGAD involves the brain, an acute disseminated encephalomyelitis (ADEM)-
like phenotype is most commonly observed; however, this is more common in pediatric or 
young adult patients. Here we report a case of late-onset MOG-immunoglobulin G (IgG)-
positive encephalomyelitis with an ADEM-like phenotype.
A 57-year-old female developed gait disturbance with recurrent falls, dysarthria, and cog-
nitive decline 3 months prior to admission to our hospital. She initially experienced recur-
rent falls and progressive bilateral lower limb weakness. One month later she experienced 
dysarthria and reduced verbal output, followed by decreased mentality, confusion, and dys-
phagia. Preceding vaccinations, systemic infections, and other neurologic symptoms were not 
reported.
On admission she was alert, but she exhibited severe dysarthria and cognitive impairment 
with decreased orientation to time and place. A neurologic examination revealed paresis of 
all extremities, which was more severe on the right side (grades 2, 3, 4, and 4 on the Medical 
Research Council scale in the right arm, right leg, left arm, and left leg, respectively). Bilateral 
upper and lower extremity deep tendon reflexes were brisk. Ankle clonus and Babinski’s sign 
were observed bilaterally. Her score on the Expanded Disability Status Scale (EDSS) was 9.5.
The results of a cerebrospinal fluid (CSF) examination were unremarkable, with a total 
nucleated cell count of 3/µL, protein level of 45 mg/dL, and glucose level of 73 mg/dL. CSF 
cytology, anti-AQP4 antibody, and CSF oligoclonal band tests were negative. Brain magnetic 
resonance imaging (MRI) fluid-attenuated inversion recovery (FLAIR) images showed mul-
tifocal hyperintense subcortical and periventricular white-matter and brainstem lesions (Fig. 
1A and B). Gadolinium (Gd)-enhanced T1-weighted images showed multiple open-ring en-
hancement patterns (Fig. 1C and D). Spinal MRI showed multiple short-segment T2-weight-
ed hyperintense lesions with partial enhancement in the cervical cord (Fig. 1E). 
Intravenous steroid pulse therapy was initiated under the clinical diagnosis of ADEM, 
with oral prednisolone and azathioprine as maintenance therapy. At that time the patient 
was found to be seropositive for anti-MOG antibodies, as determined by a live-cell fluores-
cence-activated cell-sorting assay using serum.2 Follow-up brain MRI conducted 2 weeks after 
the initial MRI scan showed decreased open-ring enhancements on the Gd-enhanced T1-
weighted images without significant changes on the FLAIR images (Fig. 1F, G, and H). Al-
though independent gait was still difficult, her dysarthria and verbal output had improved 
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significantly after steroid therapy. Her follow-up EDSS score 
was 9.0. She was transferred to the rehabilitation department 
1 month after admission. After intensive rehabilitation treat-
ment for 1 month, she was able to walk with bilateral assis-
tance, with an EDSS score of 6.5. 
This patient had monophasic and subacute encephalopathy 
that could not be explained by fever. Initial brain MRI showed 
diffuse, large, poorly demarcated lesions predominantly in-
volving the white matter, and there were no newly developed le-
sions in the follow-up MRI. These clinical and radiologic fea-
tures fulfill the diagnostic criteria of ADEM.3 
Recent studies have found that 30–50% of patients with 
Fig. 1. Brain and spine MRI of the present case. A and B: At admission, FLAIR images showed multiple hyperintense left frontal and bilateral periven-
tricular white-matter lesions. C and D: Gd-enhanced T1-weighted images showed multiple open-ring enhancement patterns (arrows). E: Multiple cer-
vical lesions with short-segment involvement were observed in spinal MRI. F, G, and H: Follow-up brain MRI after 2 weeks showed significantly de-
creased open-ring enhancement on the Gd-enhanced T1-weighted images, with minimal changes on the FLAIR images. FLAIR: fluid-attenuated inver-
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ADEM are seropositive for anti-MOG antibodies.4,5 However, 
most reported cases of MOGAD with the ADEM phenotype 
were pediatric patients or adult patients younger than 40 
years.6 Adults with MOGAD generally present with optic neu-
ritis or myelitis, and so the clinical presentation of late-onset 
anti-MOG antibody-positive ADEM has rarely been report-
ed. The case of a 49-year-old male who presented with anti-
MOG antibody-positive ADEM was reported recently.7 To the 
best of our knowledge, the present case is the first report of an-
ti-MOG antibody-positive ADEM in a patient older than 50 
years. Additionally, our patient demonstrated lesions in FLAIR 
imaging throughout the white matter, brainstem, and spinal 
cord that were more extensive than those in previously report-
ed cases. The pattern of multiple open-ring enhancements 
on Gd-enhanced T1-weighted images is also not common in 
MOGAD. Considering the age and distinct phenotype of the 
present patient in brain MRI, this report may broaden the 
understanding of the characteristics of MOGAD.
In conclusion, MOG-IgG-positive encephalomyelitis with 
an ADEM phenotype can occur in older adults, and serolog-
ic testing for anti-MOG antibodies should be considered in 
patients with late-onset ADEM.  
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